UNSPSC 85493511: Supplement right ventricle with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right ventricle with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UK4KZ

UNSPSC 85493511 Supplement right ventricle with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code for a surgical procedure that shows little relevant recent activity under state and local procurement. The recent opportunities tagged to this code—independent medical evaluation services for disability pension determinations, pharmacy benefit management, surgical carve-out networks, occupational medical surveillance, emergency services for detained youth, and temporary health professional staffing—represent procurement of medical services administration, clinical staffing, and benefits management rather than the implantation of tissue-substitute cardiac devices the code nominally describes. No state or local government solicitation in the source material reflects procurement of the surgical supplies, cardiac devices, or operative services this Commodity code is designed to classify.

State and local procurement activity under this code cannot be characterized from the available source material because the recent opportunities do not align with the code's scope. The mismatch suggests that either the code is rarely used by state and local buyers for this specific procedure, or that procurement opportunities in this medical device and surgical service category are not appearing in the recent solicitations tracked for this analysis. A business development professional evaluating opportunities under this code should verify that the issuing bodies and their procurement offices are actually sourcing cardiac implant procedures and related operative services before investing in pursuit strategy.